BioTime Expands OpRegen Clinical Trial In Dry-AMD With Opening Of First U.S. Sites Post author:Sam Post published:March 12, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Shuts Down Addiction Study After Monkey Deaths January 28, 2018 Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017 CryoLife Announces Release Date And Teleconference Call Details For 2017 First Quarter Financial Results April 10, 2017
Becton, Dickinson and Company Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock May 10, 2017
CryoLife Announces Release Date And Teleconference Call Details For 2017 First Quarter Financial Results April 10, 2017